Status:
COMPLETED
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
Lead Sponsor:
University Hospital, Lille
Conditions:
Infection Viral
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus 2019 (COVID-19) is a respiratory tropism virus transmitted through droplets emitted into the environment of infected persons. The symptoms can be extremely varied and the course can range ...
Eligibility Criteria
Inclusion
- All patient admitted in ICU Lille Hospital and hospitalized in the unit "Emergent Biological Risk" (REB) before a suspicion of infection with COVID-19
- Clinical infectious syndrome: fever (\>38°C) or hypothermia ( 36°C), chill, fever at home
- a severe respiratory table defined by:
- Oxygen demand \> 3 L/min in the presence of significant comorbidity (pregnancy, chronic respiratory disease, chronic heart disease, hemopathy, cirrhosis) or \> 6 L/min in the absence of comorbidity
- or a respiratory rate \> 30 cycles per minute
- the need for mechanical, invasive or non-invasive ventilation
- the need for humidified high-flow oxygen therapy
Exclusion
- Patient already included in study for first stay
- Cirrhosis CHILD C
- Major surgery in the last 7 days Minor patient
- Patient under guardianship or curatorship
- Refusal to participate
- No social security coverage.
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT04327180
Start Date
March 30 2020
End Date
January 30 2021
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Roger Salengro, ICU, CHU Lille
Lille, France, 59037